
ResMed shares have reached a record high after the medical device-maker posted another solid quarter of earnings growth.
The company on Friday said it made $US1.35 billion ($2.09 billion) in revenue in the three months to June 30, up 10 per cent from $US1.2 billion ($1.9 billion) from the same time in 2024.